Article
PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
28 Mar 2019
Abstract excerpt
Identifying putative biomarkers of clinical outcomes in cancer is crucial for successful enrichment, and for the selection of patients who are the most likely to benefit from a specific therapeutic approach. Indeed, current research in personalized cancer therapy focuses on the possibility of identifying biomarkers that predict prognosis, sensitivity or resistance to therapies. Phosphatase and tensin homolog...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
